RADIOIODINE ABLATIVE TREATMENT OF THYROID REMNANTS IN PATIENTS UNDERGOING TOTAL THYROIDETOMY FOR DIFFERENTIATED THYROID CANCER: WHIC THE BEST DOSE ?